Cargando…
Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial
BACKGROUND: We investigated whether Lactobacillus plantarum strain LMT1-48, isolated from Korean fermented foods and newborn feces, is a suitable probiotic supplement to treat overweight subjects. METHODS: In this randomized, double-blind, placebo-controlled clinical trial, 100 volunteers with a bod...
Autores principales: | Sohn, Minji, Jung, Hyeyoung, Lee, Woo Shun, Kim, Tai Hoon, Lim, Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925147/ https://www.ncbi.nlm.nih.gov/pubmed/35487505 http://dx.doi.org/10.4093/dmj.2021.0370 |
Ejemplares similares
-
Lactobacillus plantarum LMT1-48 exerts anti-obesity effect in high-fat diet-induced obese mice by regulating expression of lipogenic genes
por: Choi, Woo Jin, et al.
Publicado: (2020) -
Effects of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on Overweight and the Gut Microbiota in Humans: Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
por: Mo, Sung-Joon, et al.
Publicado: (2022) -
Self-Trained LMT for Semisupervised Learning
por: Fazakis, Nikos, et al.
Publicado: (2016) -
Efficacy and Safety of Lactobacillus plantarum K50 on Lipids in Koreans With Obesity: A Randomized, Double-Blind Controlled Clinical Trial
por: Sohn, Minji, et al.
Publicado: (2022) -
Lactobacillus plantarum HAC01 Supplementation Improves Glycemic Control in Prediabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Oh, Mi-Ra, et al.
Publicado: (2021)